NAFDAC Alerts Public to Counterfeit Batches of Postinor-2 in Circulation

The National Agency for Food and Drug Administration and Control (NAFDAC) has warned Nigerians about the circulation of falsified batches of Postinor-2 (Levonorgestrel 0.75mg), a widely used emergency contraceptive pill.

In a statement, NAFDAC said the falsified products were detected following a report from the Society for Family Health (SFH), which confirmed that it did not import the flagged batches.

Join our WhatsApp Channel

Investigators noted spelling and printing errors as key identifiers of the counterfeit versions. The pin verification sticker on the fake packs bears the misspelling “Veify” instead of “Verify”, while the back of the pack wrongly reads “Distnibuted in Nigeria” instead of “Distributed in Nigeria.”

READ ALSO: Human Rights Group Urges Tinubu to Halt Premature 2027 Campaigns, Tasks INEC on Electoral Integrity

Court Orders Forfeiture of N5bn Shares Linked to Ex-Army Properties MD

Product Details

  • Original Product:

Batch No: T32458H

Mfg. Date: 02/2023

Exp. Date: 02/2027

NRN No: 04-6985

  • Counterfeit Product (Type 1):

Batch No: T36184B

Mfg. Date: 08/2024

Exp. Date: 08/2028

NRN No: 04-6985

  • Counterfeit Product (Type 2):

Batch No: 332

Mfg. Date: 03/2023

Exp. Date: 02/2027

NRN No: 04-6985

NAFDAC warned that counterfeit versions of Postinor-2 may contain incorrect or harmful ingredients, unsafe dosages, or contaminants, posing serious risks such as contraceptive failure, unpredictable side effects, allergic reactions, organ damage, and possible long-term reproductive health complications.

The agency directed all its zonal directors and state coordinators to conduct surveillance and mop up the falsified products nationwide. Distributors, retailers, and healthcare professionals were also urged to remain vigilant and ensure that only genuine medicines from authorized suppliers are dispensed.

NAFDAC advised patients to report any adverse effects to its nearest office, through its e-reporting platforms. The alert will also be uploaded to the WHO Global Surveillance and Monitoring System (GSMS).

The circulation of falsified Postinor-2 underscores the growing danger of counterfeit medicines in Nigeria, highlighting the urgent need for consumer vigilance and strict regulatory enforcement to protect public health.

Chinonye
+ posts

Amanze Chinonye is a rising star in the literary world, weaving captivating stories that transport readers to the vibrant landscapes of Nigeria. With a unique voice that blends tradition with modernity, Chinonye's writing is a masterful exploration of the human condition, delving into themes of identity, culture, and social justice. Through her words, Chinonye paints vivid portraits of everyday Nigerian life, from the bustling markets of Lagos to the quiet villages of the countryside. With a keen eye for detail and a deep understanding of the complexities of Nigerian society, Chinonye's writing is both a testament to the country's rich cultural heritage and a powerful call to action for a brighter future. As a writer, Chinonye is a true storyteller, using her dexterity to educate, inspire, and uplift readers around the world.

Amanze Chinonye is a rising star in the literary world, weaving captivating stories that transport readers to the vibrant landscapes of Nigeria. With a unique voice that blends tradition with modernity, Chinonye's writing is a masterful exploration of the human condition, delving into themes of identity, culture, and social justice. Through her words, Chinonye paints vivid portraits of everyday Nigerian life, from the bustling markets of Lagos to the quiet villages of the countryside. With a keen eye for detail and a deep understanding of the complexities of Nigerian society, Chinonye's writing is both a testament to the country's rich cultural heritage and a powerful call to action for a brighter future. As a writer, Chinonye is a true storyteller, using her dexterity to educate, inspire, and uplift readers around the world.

Leave a Reply

Your email address will not be published.

Latest from Health

Don't Miss

kaskustoto kaskustoto kaskustoto kaskustoto kaskustoto kaskustoto kaskustoto kaskustoto kaskustoto kaskustoto kaskustoto kaskustoto kaskustoto kaskustoto kaskustoto kaskustoto kaskustoto kaskustoto kaskustoto kaskustoto kaskustoto kaskustoto kaskustoto kaskustoto kaskustoto kaskustoto kaskustoto kaskustoto kaskustoto kaskustoto kaskustoto